Clinical Surgery for Hepato-Pancreato-Biliary (HPB) Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 December 2024 | Viewed by 1617
Special Issue Editors
2. Pancreatic Surgery Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy
Interests: pancreatic cancer; pancreatic cysts; pancreatic diseases; pancreatic surgery; distal cholangiocarcinoma; ampullary cancer; periampullary diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hepato-biliary and pancreatic (HPB) malignancies still represent one of the most complex challenges for surgeons, both from a technical and oncological point of view. HPB malignancies range from liver ones (intrahepatic cholangiocarcinoma, Klatskin tumor, hepatocellular carcinoma, metastases from other solid neoplasms) to pancreas (pancreatic ductal adenocarcinoma, metastases from other solid malignancies, neuroendocrine neoplasms, degenerated cysts), bile duct (distal cholangiocarcinoma, Todani’s cysts) and Vater papilla (ampullary cancer) ones. Each of these malignancies require a complex multidisciplinary approach, involving gastroenterologists, endoscopists, oncologists, radiologists, pathologists and surgeons. From a surgical point of view, the treatment of these malignancies often requires a large complex procedure, exposing the patients to a high risk in terms of morbidity and mortality. However, despite their complexity, currently, many procedures can be performed via a minimally invasive approach. Despite many efforts over the last few decades, the majority of these malignancies continue to have a bad prognosis.
The aim of this Special Issue is to collect different experiences regarding the multidisciplinary management of the most frequent and important HPB diseases.
Dr. Gennaro Nappo
Dr. Michele Pagnanelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic malignancies
- HPB malignancies
- pancreatic ductal adenocarcinoma
- liver cholangiocarcinoma
- HPB surgery
- liver resection
- pancreatic resection